AXSM vs QQQ Stock Comparison
AXSM currently leads QQQ in this stock comparison, with AIQ scores of 47 vs 46. The clearest difference is value, while QQQ has the stronger quality profile.
What is the main difference between AXSM and QQQ?
AXSM leads the current stock comparison as Axsome Therapeutics, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Axsome Therapeutics, Inc. vs Invesco QQQ Trust, Series 1
AXSM leads
AXSM leads by 1 AIQ points, primarily on Value and Risk Resilience, having only recently taken the lead back from QQQ.
Fragile: 2 of 4 evidence groups support AXSM, the lead recently changed hands, and its current signal state is conflicted.
Axsome Therapeutics, Inc.
Invesco QQQ Trust, Series 1
The Algovestiq AIQ Score currently favors AXSM over QQQ, 47 versus 46 as of Nov 15, 2026. AXSM's advantage is driven primarily by stronger value and risk resilience, while QQQ holds the stronger quality profile. AXSM also shows the weaker technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor AXSM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. AXSM lead: Reversed — QQQ led by 12 AIQ points 30 sessions ago; AXSM now leads by 1.
Compare Axsome Therapeutics, Inc. and Invesco QQQ Trust, Series 1 across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AXSM and QQQ against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value65 vs 13AXSM +52
- Quality57 vs 93QQQ +36
- Risk Resilience57 vs 31AXSM +26
- Momentum24 vs 33QQQ +9
2 of 4 evidence groups favor AXSM. AXSM’s edge is concentrated in value and risk resilience; QQQ keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Value +1
New signals
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
AXSM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AXSM and QQQ both carry a full feed there.
The central trade-off
AXSM (Axsome Therapeutics, Inc.): the stronger current systematic profile, led by value and risk resilience.
QQQ (Invesco QQQ Trust, Series 1): the counter-case, on quality, momentum, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AXSMAXSM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
AXSMAXSM on the peer-relative Value factor, by 52 points.
Momentum
QQQQQQ on the Momentum factor, by 9 points.
Lower downside
AXSMAXSM on Risk Resilience, by 26 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AXSM | QQQ | Note |
|---|---|---|---|
| Implied upside to target | +83.6% | — | Level |
| Target dispersion | +21.9% | — | Lower is tighter analyst agreement |
| Consensus | Buy | — | Context, not a primary driver |
| Analysts covering | 22 | — | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 4 covered evidence groups favor AXSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 47 vs 46 |
| Fundamentals | Not covered | Not covered |
| Valuation | AXSM | Value 65 vs 13 |
| Technicals | QQQ | Price vs 50-day -17.4% vs -5.3%; vs 200-day -28.1% vs -0.3% |
| Risk Resilience | AXSM | Risk Resilience 57 vs 31 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AXSM and QQQ and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AXSM.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AXSM lead: Reversed — QQQ led by 12 AIQ points 30 sessions ago; AXSM now leads by 1.
- Today
- AXSM +1
- 47 vs 46
- 7 sessions ago
- QQQ +3
- 47 vs 50
- 30 sessions ago
- QQQ +12
- 51 vs 63
- 90 sessions ago
- AXSM +5
- 61 vs 56
The lead changed hands once in this window, most recently on Sep 25 when QQQ moved ahead of AXSM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only AXSM
- Death Cross Active — bearish, trend, long horizon (14.93%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.51%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
2 bullish / 1 bearish, conflicted
Only QQQ
- Golden Cross Active — bullish, trend, long horizon (5.22%)
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
AXSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.86%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -1.2%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1QQQ closes the Value gap — currently 52 points behind, the largest single contributor to AXSM's edge.
- 2QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
- 3AXSM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AXSM | QQQ |
|---|---|---|
| Revenue growth (YoY) | 18.9% | — |
| EPS growth (YoY) | 74.7% | — |
| Gross margin | 93.2% | — |
| Operating margin | -17.7% | — |
| Return on equity (TTM) | -12.2% | — |
| Debt to equity | 2.07 | — |
Performance
QQQ leads 5 of 6 windows| Metric | AXSM | QQQ |
|---|---|---|
| 1 week (5 sessions) | 7% | 3.6% |
| 1 month (20 sessions) | -9.8% | -4.2% |
| 3 months (63 sessions) | -34.5% | -6.8% |
| 6 months (126 sessions) | -37.8% | -4.1% |
| Year to date | -22.4% | 10.7% |
| 1 year (252 sessions) | 0.6% | 9.5% |
Technicals
QQQ has the stronger structure| Metric | AXSM | QQQ |
|---|---|---|
| RSI (14) | 40.8 | 42.8 |
| ADX (14) | 37.2 | 30.3 |
| Price vs 50-day | -17.4% | -5.3% |
| Price vs 200-day | -28.1% | -0.3% |
| Volatility (1M, annualized) | 53.2% | 35.4% |
Risk
AXSM is the more resilient| Metric | AXSM | QQQ |
|---|---|---|
| Beta | 0.66 | 1.46 |
| Sharpe ratio | 0.2 | 0.44 |
| Sortino ratio | 0.34 | 0.62 |
| Max drawdown | -49.1% | -14.8% |
| Current drawdown | -44.5% | -10.5% |
| Annualized volatility | 45.8% | 21.5% |
| Value at risk (95%) | -4.1% | -2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AXSM or QQQ?
On the Algovestiq AIQ Score, AXSM is the stronger of the two as of Nov 15, 2026, scoring 47 against QQQ's 46. The edge comes from value and risk resilience. QQQ is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AXSM or QQQ the better buy right now?
AXSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor AXSM over QQQ?
The composite weights Quality, Value, Momentum and Risk Resilience. AXSM leads Value by 52 points; QQQ leads Quality by 36 points; AXSM leads Risk Resilience by 26 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AXSM or QQQ?
Analyst price targets imply +83.6% upside for AXSM and not covered for QQQ. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AXSM or QQQ?
AXSM is the better-valued of the two on the peer-relative Value factor. AXSM on the peer-relative Value factor, by 52 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AXSM or QQQ?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AXSM or QQQ?
QQQ on the Momentum factor, by 9 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AXSM or QQQ?
AXSM is the more resilient of the two, so the other name carries the higher downside risk. AXSM on Risk Resilience, by 26 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AXSM more profitable than QQQ?
Margin data is not comparable for both names in the current snapshot.
Is AXSM's lead over QQQ getting stronger or weaker?
AXSM lead: Reversed — QQQ led by 12 AIQ points 30 sessions ago; AXSM now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-25, when QQQ moved ahead of AXSM.
What would change the AXSM vs QQQ verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: QQQ closes the Value gap — currently 52 points behind, the largest single contributor to AXSM's edge; QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; AXSM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AXSM and QQQ?
AXSM: 1 bullish / 2 bearish / 1 neutral, conflicted. QQQ: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AXSM is Death Cross Active (bearish, long horizon). On QQQ it is Golden Cross Active (bullish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.